nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—STK10—renal vein—vascular cancer	0.0727	0.198	CbGeAlD
Bosutinib—BMPR2—pulmonary artery—vascular cancer	0.0406	0.111	CbGeAlD
Bosutinib—EPHA2—pulmonary artery—vascular cancer	0.0288	0.0786	CbGeAlD
Bosutinib—BMPR2—blood vessel—vascular cancer	0.0117	0.0319	CbGeAlD
Bosutinib—PTK2—blood vessel—vascular cancer	0.00932	0.0254	CbGeAlD
Bosutinib—EPHB4—blood vessel—vascular cancer	0.00848	0.0231	CbGeAlD
Bosutinib—EPHA2—blood vessel—vascular cancer	0.00832	0.0227	CbGeAlD
Bosutinib—CLK3—cardiac atrium—vascular cancer	0.00729	0.0199	CbGeAlD
Bosutinib—SRC—blood vessel—vascular cancer	0.00721	0.0197	CbGeAlD
Bosutinib—EIF2AK1—cardiac atrium—vascular cancer	0.00705	0.0192	CbGeAlD
Bosutinib—VRK2—cardiac atrium—vascular cancer	0.00683	0.0186	CbGeAlD
Bosutinib—DMPK—cardiac atrium—vascular cancer	0.0063	0.0172	CbGeAlD
Bosutinib—WEE1—cardiac atrium—vascular cancer	0.0063	0.0172	CbGeAlD
Bosutinib—STK25—cardiac atrium—vascular cancer	0.00601	0.0164	CbGeAlD
Bosutinib—PLK2—cardiac atrium—vascular cancer	0.00585	0.0159	CbGeAlD
Bosutinib—SIK3—cardiac atrium—vascular cancer	0.00581	0.0158	CbGeAlD
Bosutinib—PDGFRB—blood vessel—vascular cancer	0.00574	0.0157	CbGeAlD
Bosutinib—CAMK1D—cardiac atrium—vascular cancer	0.00553	0.0151	CbGeAlD
Bosutinib—FER—cardiac atrium—vascular cancer	0.00528	0.0144	CbGeAlD
Bosutinib—ERBB4—cardiac atrium—vascular cancer	0.00494	0.0135	CbGeAlD
Bosutinib—BMPR2—cardiac atrium—vascular cancer	0.00474	0.0129	CbGeAlD
Bosutinib—MAP4K4—cardiac atrium—vascular cancer	0.00456	0.0124	CbGeAlD
Bosutinib—BCR—cardiac atrium—vascular cancer	0.00453	0.0123	CbGeAlD
Bosutinib—MAP3K12—cardiac atrium—vascular cancer	0.00449	0.0123	CbGeAlD
Bosutinib—STK35—cardiac atrium—vascular cancer	0.0044	0.012	CbGeAlD
Bosutinib—CSK—cardiac atrium—vascular cancer	0.00437	0.0119	CbGeAlD
Bosutinib—CSNK1A1—cardiac atrium—vascular cancer	0.00434	0.0119	CbGeAlD
Bosutinib—CLK1—cardiac atrium—vascular cancer	0.00432	0.0118	CbGeAlD
Bosutinib—SIK1—cardiac atrium—vascular cancer	0.00396	0.0108	CbGeAlD
Bosutinib—EPHA4—cardiac atrium—vascular cancer	0.00392	0.0107	CbGeAlD
Bosutinib—MAP2K2—cardiac atrium—vascular cancer	0.00388	0.0106	CbGeAlD
Bosutinib—ULK3—cardiac atrium—vascular cancer	0.00388	0.0106	CbGeAlD
Bosutinib—MAP3K7—cardiac atrium—vascular cancer	0.00381	0.0104	CbGeAlD
Bosutinib—TBK1—cardiac atrium—vascular cancer	0.00377	0.0103	CbGeAlD
Bosutinib—RPS6KB1—cardiac atrium—vascular cancer	0.00363	0.00989	CbGeAlD
Bosutinib—AXL—cardiac atrium—vascular cancer	0.00359	0.00979	CbGeAlD
Bosutinib—SLK—cardiac atrium—vascular cancer	0.00345	0.00942	CbGeAlD
Bosutinib—EPHB4—cardiac atrium—vascular cancer	0.00343	0.00935	CbGeAlD
Bosutinib—EPHA2—cardiac atrium—vascular cancer	0.00336	0.00918	CbGeAlD
Bosutinib—FYN—cardiac atrium—vascular cancer	0.00336	0.00916	CbGeAlD
Bosutinib—MAP4K5—cardiac atrium—vascular cancer	0.00328	0.00895	CbGeAlD
Bosutinib—MAP3K3—cardiac atrium—vascular cancer	0.00328	0.00895	CbGeAlD
Bosutinib—YES1—cardiac atrium—vascular cancer	0.00303	0.00827	CbGeAlD
Bosutinib—TAOK3—cardiac atrium—vascular cancer	0.00299	0.00816	CbGeAlD
Bosutinib—SRC—cardiac atrium—vascular cancer	0.00292	0.00795	CbGeAlD
Bosutinib—MAP2K5—cardiac atrium—vascular cancer	0.00268	0.00732	CbGeAlD
Bosutinib—CSF1R—cardiac atrium—vascular cancer	0.00262	0.00714	CbGeAlD
Bosutinib—PDGFRB—cardiac atrium—vascular cancer	0.00232	0.00633	CbGeAlD
Bosutinib—ABL1—cardiac atrium—vascular cancer	0.00207	0.00564	CbGeAlD
Bosutinib—ABCB1—blood vessel—vascular cancer	0.00159	0.00434	CbGeAlD
Bosutinib—FYN—Downstream signaling events of B Cell Receptor (BCR)—TSC2—vascular cancer	0.000535	0.000844	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.000533	0.000841	CbGpPWpGaD
Bosutinib—EGFR—Direct p53 effectors—TSC2—vascular cancer	0.000532	0.00084	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by PDGF—TSC2—vascular cancer	0.000531	0.000838	CbGpPWpGaD
Bosutinib—PDGFRB—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.000529	0.000836	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling by FGFR in disease—TSC2—vascular cancer	0.000529	0.000836	CbGpPWpGaD
Bosutinib—PDGFRB—DAP12 interactions—TSC2—vascular cancer	0.000529	0.000836	CbGpPWpGaD
Bosutinib—EGFR—Signaling by SCF-KIT—TSC2—vascular cancer	0.000529	0.000835	CbGpPWpGaD
Bosutinib—SRMS—Immune System—TSC2—vascular cancer	0.000527	0.000831	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling by EGFR—TSC2—vascular cancer	0.000525	0.000828	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.00052	0.000821	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—WWTR1—vascular cancer	0.00052	0.000821	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—CD34—vascular cancer	0.000519	0.000819	CbGpPWpGaD
Bosutinib—LYN—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.000518	0.000818	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling by PDGF—TSC2—vascular cancer	0.000518	0.000817	CbGpPWpGaD
Bosutinib—FYN—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.00051	0.000806	CbGpPWpGaD
Bosutinib—FYN—Signaling by FGFR in disease—TSC2—vascular cancer	0.00051	0.000806	CbGpPWpGaD
Bosutinib—FYN—DAP12 interactions—TSC2—vascular cancer	0.00051	0.000806	CbGpPWpGaD
Bosutinib—LCK—Signaling by SCF-KIT—TSC2—vascular cancer	0.00051	0.000805	CbGpPWpGaD
Bosutinib—SYK—Innate Immune System—TSC2—vascular cancer	0.000509	0.000804	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by FGFR in disease—TSC2—vascular cancer	0.000508	0.000801	CbGpPWpGaD
Bosutinib—MAP2K1—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.000508	0.000801	CbGpPWpGaD
Bosutinib—MAP2K1—DAP12 interactions—TSC2—vascular cancer	0.000508	0.000801	CbGpPWpGaD
Bosutinib—EGFR—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.000506	0.000799	CbGpPWpGaD
Bosutinib—FYN—Signaling by EGFR—TSC2—vascular cancer	0.000506	0.000799	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by EGFR—TSC2—vascular cancer	0.000503	0.000794	CbGpPWpGaD
Bosutinib—FYN—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.000501	0.000791	CbGpPWpGaD
Bosutinib—EGFR—Integrated Breast Cancer Pathway—TSC2—vascular cancer	0.000501	0.00079	CbGpPWpGaD
Bosutinib—PRKCQ—Innate Immune System—TSC2—vascular cancer	0.0005	0.000789	CbGpPWpGaD
Bosutinib—FYN—Signaling by PDGF—TSC2—vascular cancer	0.000499	0.000788	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.000499	0.000787	CbGpPWpGaD
Bosutinib—HCK—Immune System—CD34—vascular cancer	0.000498	0.000787	CbGpPWpGaD
Bosutinib—EGFR—Signaling by ERBB4—TSC2—vascular cancer	0.000498	0.000786	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by PDGF—TSC2—vascular cancer	0.000496	0.000784	CbGpPWpGaD
Bosutinib—PDGFRB—B Cell Activation—TSC2—vascular cancer	0.00049	0.000774	CbGpPWpGaD
Bosutinib—SYK—Adaptive Immune System—TSC2—vascular cancer	0.000489	0.000772	CbGpPWpGaD
Bosutinib—LCK—Downstream signaling of activated FGFR—TSC2—vascular cancer	0.000488	0.00077	CbGpPWpGaD
Bosutinib—MAP2K2—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.000481	0.000759	CbGpPWpGaD
Bosutinib—PRKCQ—Adaptive Immune System—TSC2—vascular cancer	0.00048	0.000758	CbGpPWpGaD
Bosutinib—LCK—Signaling by ERBB4—TSC2—vascular cancer	0.00048	0.000758	CbGpPWpGaD
Bosutinib—LYN—B Cell Activation—TSC2—vascular cancer	0.00048	0.000757	CbGpPWpGaD
Bosutinib—EGFR—Downstream signal transduction—TSC2—vascular cancer	0.000476	0.000751	CbGpPWpGaD
Bosutinib—EGFR—Signaling by FGFR—TSC2—vascular cancer	0.000473	0.000747	CbGpPWpGaD
Bosutinib—FYN—B Cell Activation—TSC2—vascular cancer	0.000472	0.000746	CbGpPWpGaD
Bosutinib—EGFR—Signaling by ERBB2—TSC2—vascular cancer	0.000471	0.000744	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—CD34—vascular cancer	0.000469	0.000741	CbGpPWpGaD
Bosutinib—PDGFRB—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.000469	0.00074	CbGpPWpGaD
Bosutinib—EGFR—DAP12 signaling—TSC2—vascular cancer	0.000469	0.00074	CbGpPWpGaD
Bosutinib—CSK—Adaptive Immune System—TSC2—vascular cancer	0.000464	0.000732	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—CD34—vascular cancer	0.000463	0.00073	CbGpPWpGaD
Bosutinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—TSC2—vascular cancer	0.000462	0.000729	CbGpPWpGaD
Bosutinib—LCK—Downstream signal transduction—TSC2—vascular cancer	0.000458	0.000724	CbGpPWpGaD
Bosutinib—PDGFRB—Adaptive Immune System—CD34—vascular cancer	0.000456	0.00072	CbGpPWpGaD
Bosutinib—LCK—Signaling by FGFR—TSC2—vascular cancer	0.000456	0.00072	CbGpPWpGaD
Bosutinib—LCK—Signaling by ERBB2—TSC2—vascular cancer	0.000454	0.000717	CbGpPWpGaD
Bosutinib—PHKG1—Disease—TSC2—vascular cancer	0.000452	0.000714	CbGpPWpGaD
Bosutinib—FYN—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.000452	0.000714	CbGpPWpGaD
Bosutinib—LCK—DAP12 signaling—TSC2—vascular cancer	0.000452	0.000713	CbGpPWpGaD
Bosutinib—BLK—Immune System—CD34—vascular cancer	0.000451	0.000713	CbGpPWpGaD
Bosutinib—SRC—Signaling by SCF-KIT—TSC2—vascular cancer	0.000451	0.000712	CbGpPWpGaD
Bosutinib—FGR—Immune System—CD34—vascular cancer	0.00045	0.00071	CbGpPWpGaD
Bosutinib—MAP2K1—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.00045	0.00071	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—WWTR1—vascular cancer	0.000449	0.000709	CbGpPWpGaD
Bosutinib—IRAK1—Signaling by NGF—TSC2—vascular cancer	0.000449	0.000709	CbGpPWpGaD
Bosutinib—TXK—Immune System—TSC2—vascular cancer	0.000448	0.000707	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—CD34—vascular cancer	0.000447	0.000705	CbGpPWpGaD
Bosutinib—LCK—Downstream signaling events of B Cell Receptor (BCR)—TSC2—vascular cancer	0.000445	0.000703	CbGpPWpGaD
Bosutinib—SRC—BDNF signaling pathway—TSC2—vascular cancer	0.000444	0.0007	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—WWTR1—vascular cancer	0.000443	0.000699	CbGpPWpGaD
Bosutinib—EGFR—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.000441	0.000696	CbGpPWpGaD
Bosutinib—EGFR—DAP12 interactions—TSC2—vascular cancer	0.000441	0.000696	CbGpPWpGaD
Bosutinib—EGFR—Signaling by FGFR in disease—TSC2—vascular cancer	0.000441	0.000696	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—CD34—vascular cancer	0.00044	0.000694	CbGpPWpGaD
Bosutinib—EGFR—Signaling by EGFR—TSC2—vascular cancer	0.000437	0.00069	CbGpPWpGaD
Bosutinib—EGFR—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.000433	0.000684	CbGpPWpGaD
Bosutinib—TBK1—Innate Immune System—TSC2—vascular cancer	0.000433	0.000684	CbGpPWpGaD
Bosutinib—EGFR—Signaling by PDGF—TSC2—vascular cancer	0.000431	0.000681	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—WWTR1—vascular cancer	0.000426	0.000673	CbGpPWpGaD
Bosutinib—LCK—Signaling by FGFR in disease—TSC2—vascular cancer	0.000425	0.000671	CbGpPWpGaD
Bosutinib—LCK—DAP12 interactions—TSC2—vascular cancer	0.000425	0.000671	CbGpPWpGaD
Bosutinib—LCK—Fc epsilon receptor (FCERI) signaling—TSC2—vascular cancer	0.000425	0.000671	CbGpPWpGaD
Bosutinib—LCK—Signaling by EGFR—TSC2—vascular cancer	0.000421	0.000665	CbGpPWpGaD
Bosutinib—STK4—Signaling Pathways—TSC2—vascular cancer	0.000418	0.000659	CbGpPWpGaD
Bosutinib—LCK—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.000417	0.000659	CbGpPWpGaD
Bosutinib—LCK—Signaling by PDGF—TSC2—vascular cancer	0.000416	0.000656	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—CD34—vascular cancer	0.000414	0.000653	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—WWTR1—vascular cancer	0.000411	0.000649	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—WWTR1—vascular cancer	0.000411	0.000649	CbGpPWpGaD
Bosutinib—EGFR—B Cell Activation—TSC2—vascular cancer	0.000408	0.000644	CbGpPWpGaD
Bosutinib—SRC—Downstream signal transduction—TSC2—vascular cancer	0.000406	0.000641	CbGpPWpGaD
Bosutinib—BTK—Innate Immune System—TSC2—vascular cancer	0.000404	0.000638	CbGpPWpGaD
Bosutinib—SRC—Signaling by FGFR—TSC2—vascular cancer	0.000404	0.000637	CbGpPWpGaD
Bosutinib—SRC—Signaling by ERBB2—TSC2—vascular cancer	0.000402	0.000634	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—WWTR1—vascular cancer	0.000396	0.000625	CbGpPWpGaD
Bosutinib—LCK—B Cell Activation—TSC2—vascular cancer	0.000393	0.000621	CbGpPWpGaD
Bosutinib—EGFR—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.00039	0.000617	CbGpPWpGaD
Bosutinib—BTK—Adaptive Immune System—TSC2—vascular cancer	0.000388	0.000612	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—WWTR1—vascular cancer	0.000387	0.000612	CbGpPWpGaD
Bosutinib—IRAK4—Innate Immune System—TSC2—vascular cancer	0.000386	0.000609	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—CD34—vascular cancer	0.00038	0.0006	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—WWTR1—vascular cancer	0.000378	0.000597	CbGpPWpGaD
Bosutinib—LCK—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.000376	0.000594	CbGpPWpGaD
Bosutinib—SRC—Signaling by FGFR in disease—TSC2—vascular cancer	0.000376	0.000594	CbGpPWpGaD
Bosutinib—SRC—Signaling by EGFR—TSC2—vascular cancer	0.000373	0.000589	CbGpPWpGaD
Bosutinib—HCK—Innate Immune System—TSC2—vascular cancer	0.000371	0.000585	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by NGF—TSC2—vascular cancer	0.00037	0.000584	CbGpPWpGaD
Bosutinib—SRC—Signaling by EGFR in Cancer—TSC2—vascular cancer	0.000369	0.000583	CbGpPWpGaD
Bosutinib—BCR—Disease—TSC2—vascular cancer	0.000368	0.000582	CbGpPWpGaD
Bosutinib—PTK2—Immune System—CD34—vascular cancer	0.000368	0.000582	CbGpPWpGaD
Bosutinib—SRC—Signaling by PDGF—TSC2—vascular cancer	0.000368	0.000581	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—CD34—vascular cancer	0.000366	0.000578	CbGpPWpGaD
Bosutinib—FYN—Disease—WWTR1—vascular cancer	0.000364	0.000575	CbGpPWpGaD
Bosutinib—YES1—Immune System—CD34—vascular cancer	0.000363	0.000573	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—WWTR1—vascular cancer	0.000362	0.000572	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling by NGF—TSC2—vascular cancer	0.000361	0.000569	CbGpPWpGaD
Bosutinib—STK3—Signaling Pathways—TSC2—vascular cancer	0.000355	0.000561	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—WWTR1—vascular cancer	0.000353	0.000557	CbGpPWpGaD
Bosutinib—ERBB4—Innate Immune System—TSC2—vascular cancer	0.000349	0.000551	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—WWTR1—vascular cancer	0.000348	0.000549	CbGpPWpGaD
Bosutinib—FYN—Signaling by NGF—TSC2—vascular cancer	0.000348	0.000549	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by NGF—TSC2—vascular cancer	0.000346	0.000546	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—CD34—vascular cancer	0.000344	0.000544	CbGpPWpGaD
Bosutinib—IKBKE—Immune System—TSC2—vascular cancer	0.000339	0.000536	CbGpPWpGaD
Bosutinib—ERBB4—Adaptive Immune System—TSC2—vascular cancer	0.000335	0.000529	CbGpPWpGaD
Bosutinib—FGR—Innate Immune System—TSC2—vascular cancer	0.000335	0.000528	CbGpPWpGaD
Bosutinib—SRC—NGF signalling via TRKA from the plasma membrane—TSC2—vascular cancer	0.000333	0.000526	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—WWTR1—vascular cancer	0.00033	0.000521	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—CD34—vascular cancer	0.000324	0.000512	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—CD34—vascular cancer	0.000324	0.000512	CbGpPWpGaD
Bosutinib—BLK—Adaptive Immune System—TSC2—vascular cancer	0.000322	0.000509	CbGpPWpGaD
Bosutinib—EGFR—Disease—WWTR1—vascular cancer	0.000315	0.000497	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—WWTR1—vascular cancer	0.00031	0.00049	CbGpPWpGaD
Bosutinib—ERBB3—Innate Immune System—TSC2—vascular cancer	0.000308	0.000486	CbGpPWpGaD
Bosutinib—LCK—Disease—WWTR1—vascular cancer	0.000303	0.000479	CbGpPWpGaD
Bosutinib—EGFR—Signaling by NGF—TSC2—vascular cancer	0.0003	0.000474	CbGpPWpGaD
Bosutinib—FER—Signaling Pathways—TSC2—vascular cancer	0.000298	0.00047	CbGpPWpGaD
Bosutinib—SYK—Immune System—TSC2—vascular cancer	0.000297	0.000468	CbGpPWpGaD
Bosutinib—ERBB3—Adaptive Immune System—TSC2—vascular cancer	0.000295	0.000467	CbGpPWpGaD
Bosutinib—PRKCQ—Immune System—TSC2—vascular cancer	0.000291	0.00046	CbGpPWpGaD
Bosutinib—LCK—Signaling by NGF—TSC2—vascular cancer	0.000289	0.000457	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—CD34—vascular cancer	0.000283	0.000448	CbGpPWpGaD
Bosutinib—AXL—Signaling Pathways—TSC2—vascular cancer	0.000282	0.000445	CbGpPWpGaD
Bosutinib—CSK—Immune System—TSC2—vascular cancer	0.000281	0.000444	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—CD34—vascular cancer	0.000277	0.000437	CbGpPWpGaD
Bosutinib—PTK2—Innate Immune System—TSC2—vascular cancer	0.000274	0.000432	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—WWTR1—vascular cancer	0.000271	0.000428	CbGpPWpGaD
Bosutinib—LYN—Immune System—CD34—vascular cancer	0.000271	0.000428	CbGpPWpGaD
Bosutinib—YES1—Innate Immune System—TSC2—vascular cancer	0.00027	0.000426	CbGpPWpGaD
Bosutinib—ABL1—Immune System—CD34—vascular cancer	0.00027	0.000426	CbGpPWpGaD
Bosutinib—BMPR2—Signaling Pathways—TSC2—vascular cancer	0.000269	0.000425	CbGpPWpGaD
Bosutinib—CSNK1A1—Disease—TSC2—vascular cancer	0.000269	0.000424	CbGpPWpGaD
Bosutinib—PRKCQ—Disease—TSC2—vascular cancer	0.000269	0.000424	CbGpPWpGaD
Bosutinib—SRC—Disease—WWTR1—vascular cancer	0.000269	0.000424	CbGpPWpGaD
Bosutinib—FYN—Immune System—CD34—vascular cancer	0.000267	0.000421	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—CD34—vascular cancer	0.000265	0.000419	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—WWTR1—vascular cancer	0.000265	0.000418	CbGpPWpGaD
Bosutinib—CSK—Disease—TSC2—vascular cancer	0.00026	0.00041	CbGpPWpGaD
Bosutinib—YES1—Adaptive Immune System—TSC2—vascular cancer	0.000259	0.00041	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—WWTR1—vascular cancer	0.000259	0.000409	CbGpPWpGaD
Bosutinib—BCR—Signaling Pathways—TSC2—vascular cancer	0.000258	0.000407	CbGpPWpGaD
Bosutinib—SRC—Signaling by NGF—TSC2—vascular cancer	0.000256	0.000405	CbGpPWpGaD
Bosutinib—IRAK1—Innate Immune System—TSC2—vascular cancer	0.000256	0.000404	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—WWTR1—vascular cancer	0.000255	0.000403	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—WWTR1—vascular cancer	0.000254	0.000401	CbGpPWpGaD
Bosutinib—TBK1—Immune System—TSC2—vascular cancer	0.000252	0.000398	CbGpPWpGaD
Bosutinib—CAMK2G—Immune System—TSC2—vascular cancer	0.000248	0.000391	CbGpPWpGaD
Bosutinib—MAP3K3—Immune System—TSC2—vascular cancer	0.000242	0.000382	CbGpPWpGaD
Bosutinib—MAP3K7—Innate Immune System—TSC2—vascular cancer	0.000241	0.000381	CbGpPWpGaD
Bosutinib—BTK—Immune System—TSC2—vascular cancer	0.000235	0.000371	CbGpPWpGaD
Bosutinib—MAP3K7—Adaptive Immune System—TSC2—vascular cancer	0.000232	0.000366	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CD34—vascular cancer	0.00023	0.000364	CbGpPWpGaD
Bosutinib—FES—Signaling Pathways—TSC2—vascular cancer	0.000226	0.000356	CbGpPWpGaD
Bosutinib—IRAK4—Immune System—TSC2—vascular cancer	0.000225	0.000355	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD34—vascular cancer	0.000222	0.00035	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—WWTR1—vascular cancer	0.00022	0.000348	CbGpPWpGaD
Bosutinib—CSNK1E—Disease—TSC2—vascular cancer	0.000217	0.000343	CbGpPWpGaD
Bosutinib—HCK—Immune System—TSC2—vascular cancer	0.000216	0.000341	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—WWTR1—vascular cancer	0.000212	0.000335	CbGpPWpGaD
Bosutinib—MAP2K2—Innate Immune System—TSC2—vascular cancer	0.000211	0.000333	CbGpPWpGaD
Bosutinib—PDGFRB—Innate Immune System—TSC2—vascular cancer	0.000206	0.000325	CbGpPWpGaD
Bosutinib—ERBB4—Immune System—TSC2—vascular cancer	0.000203	0.000321	CbGpPWpGaD
Bosutinib—LYN—Innate Immune System—TSC2—vascular cancer	0.000201	0.000318	CbGpPWpGaD
Bosutinib—ABL1—Innate Immune System—TSC2—vascular cancer	0.0002	0.000317	CbGpPWpGaD
Bosutinib—PTK2B—Immune System—TSC2—vascular cancer	0.0002	0.000316	CbGpPWpGaD
Bosutinib—HCK—Disease—TSC2—vascular cancer	0.000199	0.000315	CbGpPWpGaD
Bosutinib—FYN—Innate Immune System—TSC2—vascular cancer	0.000198	0.000313	CbGpPWpGaD
Bosutinib—PDGFRB—Adaptive Immune System—TSC2—vascular cancer	0.000198	0.000312	CbGpPWpGaD
Bosutinib—MAP2K1—Innate Immune System—TSC2—vascular cancer	0.000197	0.000311	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD34—vascular cancer	0.000197	0.00031	CbGpPWpGaD
Bosutinib—BLK—Immune System—TSC2—vascular cancer	0.000196	0.000309	CbGpPWpGaD
Bosutinib—FGR—Immune System—TSC2—vascular cancer	0.000195	0.000308	CbGpPWpGaD
Bosutinib—LYN—Adaptive Immune System—TSC2—vascular cancer	0.000193	0.000305	CbGpPWpGaD
Bosutinib—SYK—Signaling Pathways—TSC2—vascular cancer	0.000192	0.000303	CbGpPWpGaD
Bosutinib—FYN—Adaptive Immune System—TSC2—vascular cancer	0.00019	0.000301	CbGpPWpGaD
Bosutinib—CSNK1A1—Signaling Pathways—TSC2—vascular cancer	0.000188	0.000297	CbGpPWpGaD
Bosutinib—PRKCQ—Signaling Pathways—TSC2—vascular cancer	0.000188	0.000297	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—WWTR1—vascular cancer	0.000188	0.000297	CbGpPWpGaD
Bosutinib—ERBB4—Disease—TSC2—vascular cancer	0.000188	0.000296	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—TSC2—vascular cancer	0.000182	0.000287	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—TSC2—vascular cancer	0.000179	0.000283	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—TSC2—vascular cancer	0.000171	0.00027	CbGpPWpGaD
Bosutinib—ERBB3—Disease—TSC2—vascular cancer	0.000165	0.000261	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—TSC2—vascular cancer	0.000165	0.000261	CbGpPWpGaD
Bosutinib—EGFR—Adaptive Immune System—TSC2—vascular cancer	0.000164	0.00026	CbGpPWpGaD
Bosutinib—PTK2—Immune System—TSC2—vascular cancer	0.00016	0.000252	CbGpPWpGaD
Bosutinib—LCK—Adaptive Immune System—TSC2—vascular cancer	0.000159	0.00025	CbGpPWpGaD
Bosutinib—YES1—Immune System—TSC2—vascular cancer	0.000157	0.000248	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—TSC2—vascular cancer	0.000152	0.00024	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—TSC2—vascular cancer	0.000149	0.000236	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—TSC2—vascular cancer	0.000146	0.000231	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—TSC2—vascular cancer	0.00014	0.000222	CbGpPWpGaD
Bosutinib—SRC—Adaptive Immune System—TSC2—vascular cancer	0.00014	0.000222	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—WWTR1—vascular cancer	0.000133	0.00021	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—TSC2—vascular cancer	0.000131	0.000208	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—TSC2—vascular cancer	0.00013	0.000205	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—TSC2—vascular cancer	0.000125	0.000197	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—TSC2—vascular cancer	0.000123	0.000194	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TSC2—vascular cancer	0.00012	0.00019	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TSC2—vascular cancer	0.00012	0.00019	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—TSC2—vascular cancer	0.00012	0.000189	CbGpPWpGaD
Bosutinib—LYN—Immune System—TSC2—vascular cancer	0.000117	0.000185	CbGpPWpGaD
Bosutinib—ABL1—Immune System—TSC2—vascular cancer	0.000117	0.000184	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TSC2—vascular cancer	0.000116	0.000183	CbGpPWpGaD
Bosutinib—FYN—Immune System—TSC2—vascular cancer	0.000115	0.000182	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—TSC2—vascular cancer	0.000115	0.000181	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—TSC2—vascular cancer	0.000113	0.000179	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—TSC2—vascular cancer	0.000111	0.000175	CbGpPWpGaD
Bosutinib—FYN—Disease—TSC2—vascular cancer	0.000107	0.000168	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—TSC2—vascular cancer	0.000106	0.000167	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TSC2—vascular cancer	0.000103	0.000163	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TSC2—vascular cancer	0.000102	0.000161	CbGpPWpGaD
Bosutinib—EGFR—Immune System—TSC2—vascular cancer	9.98e-05	0.000158	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TSC2—vascular cancer	9.65e-05	0.000152	CbGpPWpGaD
Bosutinib—LCK—Immune System—TSC2—vascular cancer	9.61e-05	0.000152	CbGpPWpGaD
Bosutinib—EGFR—Disease—TSC2—vascular cancer	9.21e-05	0.000145	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TSC2—vascular cancer	9.08e-05	0.000143	CbGpPWpGaD
Bosutinib—LCK—Disease—TSC2—vascular cancer	8.88e-05	0.00014	CbGpPWpGaD
Bosutinib—SRC—Immune System—TSC2—vascular cancer	8.51e-05	0.000134	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—WWTR1—vascular cancer	8.2e-05	0.000129	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TSC2—vascular cancer	7.94e-05	0.000125	CbGpPWpGaD
Bosutinib—SRC—Disease—TSC2—vascular cancer	7.86e-05	0.000124	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TSC2—vascular cancer	7.75e-05	0.000122	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TSC2—vascular cancer	7.58e-05	0.00012	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TSC2—vascular cancer	7.47e-05	0.000118	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—HBA1—vascular cancer	7.45e-05	0.000118	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TSC2—vascular cancer	7.43e-05	0.000117	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TSC2—vascular cancer	6.45e-05	0.000102	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TSC2—vascular cancer	6.22e-05	9.81e-05	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TSC2—vascular cancer	5.5e-05	8.69e-05	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—HBA1—vascular cancer	4.59e-05	7.25e-05	CbGpPWpGaD
